Correlation Between X4 Pharmaceuticals and Arcus Biosciences
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Arcus Biosciences, you can compare the effects of market volatilities on X4 Pharmaceuticals and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Arcus Biosciences.
Diversification Opportunities for X4 Pharmaceuticals and Arcus Biosciences
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between XFOR and Arcus is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Arcus Biosciences go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Arcus Biosciences
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 4.04 times more return on investment than Arcus Biosciences. However, X4 Pharmaceuticals is 4.04 times more volatile than Arcus Biosciences. It trades about -0.01 of its potential returns per unit of risk. Arcus Biosciences is currently generating about -0.04 per unit of risk. If you would invest 50.00 in X4 Pharmaceuticals on August 29, 2024 and sell it today you would lose (15.00) from holding X4 Pharmaceuticals or give up 30.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Arcus Biosciences
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Arcus Biosciences |
X4 Pharmaceuticals and Arcus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Arcus Biosciences
The main advantage of trading using opposite X4 Pharmaceuticals and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals | X4 Pharmaceuticals vs. Seres Therapeutics |
| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |